过去一年中添加的文章,按日期排序

[PDF][PDF] Comparison of NSAID and ASA usage across the colorectal screening study groups

V Zaric - 2024 - duo.uio.no
6 天前 - … Background Colorectal cancer (CRC) is the third most commonly diagnosed
cancer and the second leading cause of cancer-related deaths. CRC develops from colorectal

A Rare Case Report: 23-Year-Old Man with Ascending Colon Cancer with Napkin's Ring Appearance

M Arifin, D Lestari - International Journal of Social Health, 2024 - ijsh.ph.asianpublisher.org
6 天前 - Colorectal Cancer, Napkin’s Ring, Laparotomy, Hemicolectomy Colorectal cancer
is a … due to improved screening and treatment, colorectal cancer remains a leading cause of …

Advanced Lung Cancer Inflammation Index: A Novel Comprehensive Biomarker of Host Status for Patients with Metastatic Colorectal Cancer

T Horino, R Tokunaga, Y Miyamoto… - Journal of the Anus …, 2024 - jstage.jst.go.jp
6 天前 - … inflammation index (ALI), initially introduced as a screening tool for patients with
non-small-cell lung cancer in 2013, emerges as a holistic marker encompassing all body …

QPH-FR: A Novel Quinoa Peptide Enhances Chemosensitivity by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 in Colorectal Cancer

J Tian, L Zhang, X La, Y An, X Fan… - Journal of Agricultural and …, 2024 - ACS Publications
6 天前 - Chemoresistance is one of the difficulties in the treatment of colorectal cancer (CRC), …
Further, the most effective peptide QPH-FR from 631 peptides in QPH was screened by …

AFDN deficiency promotes liver tropism of metastatic colorectal cancer

S Liao, J Deng, M Deng, C Chen, F Han, K Ye… - Cancer …, 2024 - aacrjournals.org
6 天前 - … loss-of-function screening in a mouse colorectal cancer 42 model and identified
deficiency … survival in patients with colorectal cancer. AFDN-deficient colorectal cancer cells 45 …

[HTML][HTML] Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials

Y Zhan, X Cheng, P Mei, S Tan, W Feng, H Jiang - BMC cancer, 2024 - Springer
6 天前 - … therapy for metastatic colorectal cancer through network … criteria were applied
to screen studies. The Cochrane Bias … 17,351 patients with metastatic colorectal cancer (mCRC), …

[HTML][HTML] In vivo interaction screening reveals liver-derived constraints to metastasis

C Borrelli, M Roberts, D Eletto, MD Hussherr, H Fazilaty… - Nature, 2024 - nature.com
6 天前 - … Here we devised a screening approach for functional testing of cell–cell interactions
in … signals promote or suppress seeding of colorectal cancer (CRC) liver metastases and …

Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity

W Li, C Yang, Z Cheng, Y Wu, S Zhou, X Qi… - MedComm, 2024 - Wiley Online Library
7 天前 - Colorectal cancer (CRC) is one of the most common malignancies worldwide. In
the … In this study, we screened and established the gallium complex K6 as a potent antitumor …

A multi-cancer early detection (MCED) test: clinical update for GPs

T Save, RD Neal, T Round - British Journal of General Practice, 2024 - bjgp.org
7 天前 - Cancer screening can be effective at early-stage … cancers in the UK are screendetected
with programmes for cervical, colorectal, breast, and more recently targeted lung cancer

The comparison of fecal occult blood test screening and flexible sigmoidoscopy in reducing mortality risk in colorectal cancer patients: Systematic review and meta …

BP Wibowo - Jurnal Penyakit Dalam Udayana, 2024 - jpdunud.org
7 天前 - Screening in colorectal cancer patients is expected … colorectal cancer patients.
Fecal occult blood test (FOBT) and flexible sigmoidoscopy (FS) are colorectal cancer screening